Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. [AUT. KORESP.] MILTON PACKER, [AUT.] JOHN J.V. MCMURRAY, AKSHAY S. DESAI, JIANJIAN GONG, MARTIN P. LEFKOWITZ, ADEL R. RIZKALA, JEAN L. ROULEAU, VICTOR C. SHI, SCOTT D. SOLOMON, KARL SWEDBERG, MICHAEL ZILE, KARL ANDERSEN, JUAN L. ARANGO, J. MALCOLM ARNOLD, JAN BĔLOHLÁVEK, MICHAEL BÖHM, SERGEY BOYTSOV, LESLEY J. BURGESS, WALTER CABRERA, CARLOS CALVO, CHEN-HUAN CHEN, ANDREJ DUKAT, YAN C. DUARTE, ANDREJS ERGLIS, MICHAEL FU, EFRAIN GOMEZ, ANGEL GONZÀLEZ-MEDINA, ABERT A. HAGÈGE, JUN HUANG, TZVETANA KATOVA, SONGSAK KIATCHOOSAKUN, KEE-SIK KIM, ÖMER KOZAN, EDMUNDO B. LLAMAS, FELIPE MARTINEZ, BELA MERKELY, IVÁN MENDOZA, AREND MOSTERD, MARTA NEGRUSZ-KAWECKA, KEIJO PEUHKURINEN, FELIX J.A. RAMIRES, JENS REFSGAARD, ARVO ROSENTHAL, MICHELE SENNI, ANTONIO S. SIBULO, JOSÉ SILVA-CARDOSO, IAIN B. SQUIRE, RANDALL C. STARLING, JOHN R. TEERLINK, JOHAN VANHAECKE, DRAGOS VINEREANU, RAYMOND CHING-CHIEW WONG, PARADIGM-HF COMMITTEES AND INVESTIGATORS AND COORDINATORS [M. IN.], Z[BIGNIEW] PIJANOWSKI. Circulation 2015 vol. 131 nr 1 s. 54-61, bibliogr. poz. 42. DOI: 10.1161/CIRCULATIONAHA.114.013748

✓ Skopiowane!